Alembic Pharmaceuticals Board Meeting Date
Alembic Pharmaceuticals scheduled its board meeting for November 4, 2026, to consider unaudited Q1/H1 FY27 results. Trading window re-opens 48 hours post-declaration.
ALFA Filings
Every announcement, straight from the exchange
Every Alembic Pharmaceuticals board meeting date announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Alembic Pharmaceuticals scheduled its board meeting for November 4, 2026, to consider unaudited Q1/H1 FY27 results. Trading window re-opens 48 hours post-declaration.
Alembic Pharmaceuticals has scheduled a board meeting on August 4, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Alembic Pharmaceuticals Ltd has scheduled a Board Meeting on May 15, 2026. The board will consider and approve audited financial results for the quarter and year ended March 31, 2026, and recommend a dividend. The trading window remains closed until 48 hours after the results declaration.